Inspiring Hope Together: Canadian Association for Suicide Prevention Announces National Suicide Prevention Conference in Vancouver, BC
April 04, 2024 11:45 ET
|
Canadian Association for Suicide Prevention
National Suicide Prevention Conference convenes from May 29-May 31, 2024 in Vancouver. “Inspiring Hope Together,” the transformative power of unity.
Pixalate Releases Global Q4 2023 CTV FAST Apps Rankings & Traffic Analysis Report for Samsung Smart TV: 5% Higher Invalid Traffic (IVT) Rate on FAST Apps
April 04, 2024 08:00 ET
|
Pixalate Inc.
LONDON, April 04, 2024 (GLOBE NEWSWIRE) -- Pixalate, the market-leading fraud protection, privacy, and compliance analytics platform for Connected TV (CTV) and Mobile Advertising, today released the...
Pixalate Releases Global Q4 2023 CTV FAST Apps Rankings & Traffic Analysis Report for Roku: 17% Higher Invalid Traffic (IVT) Rate on Non-FAST Apps
April 04, 2024 08:00 ET
|
Pixalate Inc.
LONDON, April 04, 2024 (GLOBE NEWSWIRE) -- Pixalate, the market-leading fraud protection, privacy, and compliance analytics platform for Connected TV (CTV) and Mobile Advertising, today released the...
PROTEIN INDUSTRIES CANADA OPENS CALL FOR TECHNOLOGY LEADERSHIP PROJECTS
April 02, 2024 12:00 ET
|
Protein Industries Canada
Regina, SK, April 02, 2024 (GLOBE NEWSWIRE) -- Protein Industries Canada is opening their third call for proposals under their Technology Leadership Project program stream. The call, which will...
Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation as the Company Conducts Two Pivotal Studies for Revita in Obesity and Type 2 Diabetes
April 02, 2024 08:00 ET
|
Fractyl Health, Inc.
Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation
Fractyl Health Receives FDA IDE Approval for the Revita® Remain-1 Pivotal Study of Weight Maintenance in Obesity after Discontinuation of GLP-1 Based Drugs
April 01, 2024 06:00 ET
|
Fractyl Health, Inc.
Fractyl Health Receives FDA IDE Approval for the Revita® Remain-1 Pivotal Study of Weight Maintenance in Obesity after Discontinuation of GLP-1 Based Drugs
Pixalate’s February 2024 Ad Fraud Research on Global CTV App Spoofing for Roku, Amazon Fire TV, Samsung Smart TV, and Apple TV: 4.6% of CTV Traffic is Spoofed - ESPN, Fubo, Among Most-Spoofed Apps
March 28, 2024 17:36 ET
|
Pixalate Inc.
LONDON, March 28, 2024 (GLOBE NEWSWIRE) -- Pixalate, the market-leading fraud protection, privacy, and compliance analytics platform for Connected TV (CTV) and Mobile Advertising, today released the...
SOFTSWISS Unveils South African iGaming Market Overview
March 28, 2024 11:52 ET
|
SOFTSWISS
SOFTSWISS Unveils South African iGaming Market Overview, exploring peculiarities like provincial licensing, sports betting, gaming preferences, etc.
atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
March 28, 2024 07:00 ET
|
atai Life Sciences
Strategic investment in Beckley Psytech to accelerate the development of psychedelic-based therapies that fit within the two hour in-clinic treatment paradigm established by Spravato®Initial BPL-003...
[Latest] Global PARP Inhibitors Market Size/Share Worth USD 23.5 Billion by 2032 at a 12.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
March 27, 2024 14:30 ET
|
Custom Market Insights
Austin, TX, USA, March 28, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “PARP Inhibitors Market Size, Trends and Insights By Type (Olaparib, Rucaparib,...